Literature DB >> 30142438

Major intra-familial phenotypic heterogeneity and incomplete penetrance due to a CACNA1A pathogenic variant.

Chloé Angelini1, Julien Van Gils2, Antoine Bigourdan3, Pierre-Simon Jouk4, Didier Lacombe2, Patrice Menegon3, Sébastien Moutton5, Florence Riant6, Guilhem Sole7, Elisabeth Tournier-Lasserve6, Aurélien Trimouille2, Marie Vincent8, Cyril Goizet9.   

Abstract

The CACNA1A gene encodes a calcium-dependent voltage channel, localized in neuronal cells. Pathogenic variants in this gene are known to lead to a broad clinical spectrum including episodic ataxia type 2, spinocerebellar ataxia type 6, familial hemiplegic migraine, and more recently epileptic encephalopathy. We report a large family revealing a wide variability of neurological manifestations associated with a CACNA1A missense pathogenic variant. The index case had early-onset epileptic encephalopathy with progressive cerebellar atrophy, although his mother and his great-grandmother suffered from paroxystic episodic ataxia. His grandfather and great grand-aunt reported no symptoms, but two of her sons displayed early-onset ataxia with intellectual disability. Two of her little daughters suffered from gait disorders, and also from epilepsy for one of them. All these relatives were carriers of the previously described heterozygous variant in CACNA1A gene. We report here the first family leading to major clinical variability and incomplete penetrance. Our family highlights the difficulties to provide accurate genetic counselling concerning prenatal diagnosis regarding highly variable severity of the clinical presentation.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Ataxia; CACNA1A; Epileptic encephalopathy; Genetic counselling; Incomplete penetrance

Mesh:

Substances:

Year:  2018        PMID: 30142438     DOI: 10.1016/j.ejmg.2018.08.011

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  13 in total

1.  Epilepsy and episodic ataxia type 2: family study and review of the literature.

Authors:  Lorenzo Verriello; Giada Pauletto; Annacarmen Nilo; Incoronata Lonigro; Elena Betto; Mariarosaria Valente; Francesco Curcio; Gian Luigi Gigli
Journal:  J Neurol       Date:  2021-05-13       Impact factor: 4.849

2.  Clinical and genetic characterization of CACNA1A-related disease.

Authors:  Amy R Lipman; Xiao Fan; Yufeng Shen; Wendy K Chung
Journal:  Clin Genet       Date:  2022-06-26       Impact factor: 4.296

3.  Application of a custom NGS gene panel revealed a high diagnostic utility for molecular testing of hereditary ataxias.

Authors:  Wiktoria Radziwonik; Ewelina Elert-Dobkowska; Aleksandra Klimkowicz-Mrowiec; Karolina Ziora-Jakutowicz; Iwona Stepniak; Jacek Zaremba; Anna Sulek
Journal:  J Appl Genet       Date:  2022-05-19       Impact factor: 2.653

4.  The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders.

Authors:  Anna Alkelai; Lior Greenbaum; Anna R Docherty; Andrey A Shabalin; Gundula Povysil; Ayan Malakar; Daniel Hughes; Shannon L Delaney; Emma P Peabody; James McNamara; Sahar Gelfman; Evan H Baugh; Anthony W Zoghbi; Matthew B Harms; Hann-Shyan Hwang; Anat Grossman-Jonish; Vimla Aggarwal; Erin L Heinzen; Vaidehi Jobanputra; Ann E Pulver; Bernard Lerer; David B Goldstein
Journal:  Mol Psychiatry       Date:  2021-11-19       Impact factor: 13.437

5.  The complexities of CACNA1A in clinical neurogenetics.

Authors:  Marina P Hommersom; Teije H van Prooije; Maartje Pennings; Meyke I Schouten; Hans van Bokhoven; Erik-Jan Kamsteeg; Bart P C van de Warrenburg
Journal:  J Neurol       Date:  2021-11-22       Impact factor: 6.682

6.  Germline variants in tumor suppressor FBXW7 lead to impaired ubiquitination and a neurodevelopmental syndrome.

Authors:  Sarah E M Stephenson; Gregory Costain; Laura E R Blok; Michael A Silk; Thanh Binh Nguyen; Xiaomin Dong; Dana E Alhuzaimi; James J Dowling; Susan Walker; Kimberly Amburgey; Robin Z Hayeems; Lance H Rodan; Marc A Schwartz; Jonathan Picker; Sally A Lynch; Aditi Gupta; Kristen J Rasmussen; Lisa A Schimmenti; Eric W Klee; Zhiyv Niu; Katherine E Agre; Ilana Chilton; Wendy K Chung; Anya Revah-Politi; P Y Billie Au; Christopher Griffith; Melissa Racobaldo; Annick Raas-Rothschild; Bruria Ben Zeev; Ortal Barel; Sebastien Moutton; Fanny Morice-Picard; Virginie Carmignac; Jenny Cornaton; Nathalie Marle; Orrin Devinsky; Chandler Stimach; Stephanie Burns Wechsler; Bryan E Hainline; Katie Sapp; Marjolaine Willems; Ange-Line Bruel; Kerith-Rae Dias; Carey-Anne Evans; Tony Roscioli; Rani Sachdev; Suzanna E L Temple; Ying Zhu; Joshua J Baker; Ingrid E Scheffer; Fiona J Gardiner; Amy L Schneider; Alison M Muir; Heather C Mefford; Amy Crunk; Elizabeth M Heise; Francisca Millan; Kristin G Monaghan; Richard Person; Lindsay Rhodes; Sarah Richards; Ingrid M Wentzensen; Benjamin Cogné; Bertrand Isidor; Mathilde Nizon; Marie Vincent; Thomas Besnard; Amelie Piton; Carlo Marcelis; Kohji Kato; Norihisa Koyama; Tomoo Ogi; Elaine Suk-Ying Goh; Christopher Richmond; David J Amor; Jessica O Boyce; Angela T Morgan; Michael S Hildebrand; Antony Kaspi; Melanie Bahlo; Rún Friðriksdóttir; Hildigunnur Katrínardóttir; Patrick Sulem; Kári Stefánsson; Hans Tómas Björnsson; Simone Mandelstam; Manuela Morleo; Milena Mariani; Marcello Scala; Andrea Accogli; Annalaura Torella; Valeria Capra; Mathew Wallis; Sandra Jansen; Quinten Weisfisz; Hugoline de Haan; Simon Sadedin; Sze Chern Lim; Susan M White; David B Ascher; Annette Schenck; Paul J Lockhart; John Christodoulou; Tiong Yang Tan
Journal:  Am J Hum Genet       Date:  2022-04-07       Impact factor: 11.043

Review 7.  Paroxysmal Movement Disorders.

Authors:  Susan Harvey; Mary D King; Kathleen M Gorman
Journal:  Front Neurol       Date:  2021-06-11       Impact factor: 4.003

8.  Two distinct phenotypes, hemiplegic migraine and episodic Ataxia type 2, caused by a novel common CACNA1A variant.

Authors:  Rosaria Nardello; Giorgia Plicato; Giuseppe Donato Mangano; Elena Gennaro; Salvatore Mangano; Filippo Brighina; Vincenzo Raieli; Antonina Fontana
Journal:  BMC Neurol       Date:  2020-04-26       Impact factor: 2.474

Review 9.  Episodic Ataxias: Faux or Real?

Authors:  Paola Giunti; Elide Mantuano; Marina Frontali
Journal:  Int J Mol Sci       Date:  2020-09-05       Impact factor: 5.923

10.  A novel pathogenic CACNA1A variant causing episodic ataxia type 2 (EA2) spectrum phenotype in four family members and a novel combined therapy.

Authors:  Josef Penkava; S Ledderose; S Chahrokh-Zadeh; A Munzig; Zu Eulenburg; D Huppert; M Strupp; S Becker-Bense
Journal:  J Neurol       Date:  2020-09-10       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.